
An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.

An experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.